Holger Hess‐Stumpp

2.9k total citations
34 papers, 1.5k citations indexed

About

Holger Hess‐Stumpp is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Holger Hess‐Stumpp has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Holger Hess‐Stumpp's work include Cancer, Hypoxia, and Metabolism (14 papers), Endometriosis Research and Treatment (6 papers) and Epigenetics and DNA Methylation (4 papers). Holger Hess‐Stumpp is often cited by papers focused on Cancer, Hypoxia, and Metabolism (14 papers), Endometriosis Research and Treatment (6 papers) and Epigenetics and DNA Methylation (4 papers). Holger Hess‐Stumpp collaborates with scholars based in Germany, United States and Switzerland. Holger Hess‐Stumpp's co-authors include Karl‐Heinz Thierauch, Oliver Politz, David Henderson, Kristof Chwalisż, Kerstin Unterschemmann, Sven Christian, Jens Hoffmann, Peter Ellinghaus, Karl Ziegelbauer and Martin Haberey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cell Metabolism and Cancer Research.

In The Last Decade

Holger Hess‐Stumpp

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Holger Hess‐Stumpp Germany 18 973 430 307 180 163 34 1.5k
Lucia Cicchillitti Italy 23 1.0k 1.0× 463 1.1× 370 1.2× 129 0.7× 113 0.7× 31 1.5k
Silvia Fernández de Mattos Spain 18 1.1k 1.2× 208 0.5× 355 1.2× 118 0.7× 231 1.4× 31 1.6k
Shi-Wen Jiang United States 21 1.0k 1.1× 231 0.5× 179 0.6× 207 1.1× 109 0.7× 30 1.5k
Clark M. Whitehead United States 17 988 1.0× 178 0.4× 380 1.2× 139 0.8× 90 0.6× 24 1.5k
Yuji Yaginuma Japan 19 646 0.7× 208 0.5× 424 1.4× 117 0.7× 164 1.0× 51 1.2k
Gary K. Yiu United States 13 990 1.0× 245 0.6× 379 1.2× 282 1.6× 137 0.8× 15 1.5k
Daniela Califano Italy 29 1.6k 1.6× 577 1.3× 964 3.1× 174 1.0× 244 1.5× 62 2.6k
Felix Zeppernick Germany 17 609 0.6× 384 0.9× 691 2.3× 343 1.9× 168 1.0× 40 1.6k
Martina L. Skrede Norway 16 520 0.5× 247 0.6× 241 0.8× 93 0.5× 118 0.7× 22 1.0k
R. Gätje Germany 16 507 0.5× 206 0.5× 291 0.9× 106 0.6× 85 0.5× 24 865

Countries citing papers authored by Holger Hess‐Stumpp

Since Specialization
Citations

This map shows the geographic impact of Holger Hess‐Stumpp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Hess‐Stumpp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Hess‐Stumpp more than expected).

Fields of papers citing papers by Holger Hess‐Stumpp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Hess‐Stumpp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Hess‐Stumpp. The network helps show where Holger Hess‐Stumpp may publish in the future.

Co-authorship network of co-authors of Holger Hess‐Stumpp

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Hess‐Stumpp. A scholar is included among the top collaborators of Holger Hess‐Stumpp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Hess‐Stumpp. Holger Hess‐Stumpp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Manman, Thomas T. Tapmeier, Sanjiv Manek, et al.. (2020). Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study. BMC Medicine. 18(1). 3–3. 59 indexed citations
2.
Grünewald, Sylvia, Oliver Politz, Sebastian Bender, et al.. (2019). Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models. International Journal of Cancer. 145(5). 1346–1357. 72 indexed citations
3.
Adam, Mohamed, Sonja Matt, Sven Christian, et al.. (2015). SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status. Cell Cycle. 14(23). 3734–3747. 27 indexed citations
4.
5.
Héroult, Mélanie, Peter Ellinghaus, Dirk Brohm, et al.. (2014). Abstract 1739: Preclinical profile of BAY 1163877 - a selective pan-FGFR inhibitor in phase 1 clinical trial. Cancer Research. 74(19_Supplement). 1739–1739. 9 indexed citations
6.
Härter, Michael, Karl‐Heinz Thierauch, Ajay Bhargava, et al.. (2013). Inhibition of Hypoxia‐Induced Gene Transcription by Substituted Pyrazolyl Oxadiazoles: Initial Lead Generation and Structure–Activity Relationships. ChemMedChem. 9(1). 61–66. 5 indexed citations
7.
Koi, Lydia, Kerstin Brüchner, Kristin Gurtner, et al.. (2013). Hypoxia-Inducible Factor Pathway Inhibition Resolves Tumor Hypoxia and Improves Local Tumor Control After Single-Dose Irradiation. International Journal of Radiation Oncology*Biology*Physics. 88(1). 159–166. 29 indexed citations
8.
Hess‐Stumpp, Holger, et al.. (2011). LDH-A influences hypoxia-inducible factor 1α (HIF1 α) and is critical for growth of HT29 colon carcinoma cells in vivo. Targeted Oncology. 6(3). 155–162. 33 indexed citations
9.
Haerter, Michael, Peter Ellinghaus, Iring Heisler, et al.. (2011). Abstract 4509: BAY 87-2243 targets hypoxia-induced activation and stabilization of HIF-1α: A novel approach to overcome resistance mechanisms in cancer therapy. Cancer Research. 71(8_Supplement). 4509–4509. 2 indexed citations
10.
11.
Altmann, Annette, Michael Eisenhut, Ulrike Bauder‐Wüst, et al.. (2010). Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275. European Journal of Nuclear Medicine and Molecular Imaging. 37(12). 2286–2297. 14 indexed citations
12.
Samaržija, Ivana, Fabienne Baffert, Amanda Littlewood‐Evans, et al.. (2008). Inhibition of Multiple Vascular Endothelial Growth Factor Receptors (VEGFR) Blocks Lymph Node Metastases but Inhibition of VEGFR-2 Is Sufficient to Sensitize Tumor Cells to Platinum-Based Chemotherapeutics. Cancer Research. 68(5). 1581–1592. 32 indexed citations
13.
Hoffmann, Jens, Iduna Fichtner, M Lemm, et al.. (2008). Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases. Neuro-Oncology. 11(2). 158–166. 60 indexed citations
14.
Thierauch, Karl‐Heinz, Martin Haberey, Holger Hess‐Stumpp, et al.. (2007). ZK 261991. a novel VEGFR inhibitor for tumor therapy. Cancer Research. 67. 2135–2135. 1 indexed citations
15.
Hess‐Stumpp, Holger, et al.. (2007). MS-275, a potent orally available inhibitor of histone deacetylases—The development of an anticancer agent. The International Journal of Biochemistry & Cell Biology. 39(7-8). 1388–1405. 127 indexed citations
16.
Schmidt, Anja, Bernard Haendler, Holger Hess‐Stumpp, et al.. (2006). Gene Expression During the Implantation Window: Microarray Analysis of Human Endometrial Samples. PubMed. 139–157. 7 indexed citations
17.
Slayden, Ov D., Mary B. Zelinski, Kristof Chwalisż, Holger Hess‐Stumpp, & Robert Brenner. (2006). Chronic progesterone antagonist–estradiol therapy suppresses breakthrough bleeding and endometrial proliferation in a menopausal macaque model. Human Reproduction. 21(12). 3081–3090. 9 indexed citations
18.
Haendler, Bernard, Hiroshi Yamanouchi, Bruce A. Lessey, Kristof Chwalisż, & Holger Hess‐Stumpp. (2004). Cycle‐dependent endometrial expression and hormonal regulation of the fibulin‐1 gene. Molecular Reproduction and Development. 68(3). 279–287. 18 indexed citations
19.
Hess‐Stumpp, Holger, Jens Hoffmann, & Astrid Schott. (2004). 82 MS-275, a potent orally active inhibitor of histone deacetylases is highly active in experimental tumor models of melanoma and prostate cancer. European Journal of Cancer Supplements. 2(8). 28–28. 1 indexed citations
20.
DeManno, Deborah A., W. Elger, Ronald Lee, et al.. (2003). Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy. Steroids. 68(10-13). 1019–1032. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lucia Cicchillitti Breakdown of academic impact, for papers by Silvia Fernández de Mattos Breakdown of academic impact, for papers by Shi-Wen Jiang Breakdown of academic impact, for papers by Clark M. Whitehead Breakdown of academic impact, for papers by Yuji Yaginuma Breakdown of academic impact, for papers by Gary K. Yiu Breakdown of academic impact, for papers by Daniela Califano Breakdown of academic impact, for papers by Felix Zeppernick Breakdown of academic impact, for papers by Martina L. Skrede Breakdown of academic impact, for papers by R. Gätje
Rankless by CCL
2026